Renu Virmani
Armed Forces Institute of Pathology
1085 Papers
7.7K Citations
Renu Virmani is an academic researcher from Armed Forces Institute of Pathology. The author has contributed to research in topics: Medicine & Stent. The author has an hindex of 154, co-authored 998 publications.
Chat about Author
Papers
•Journal Article
Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents.
Saami K. Yazdani,Alexander Sheehy,Masataka Nakano,Gaku Nakazawa,Marc Vorpahl,Fumiyuki Otsuka,Rosy S Donn,Laura E. Perkins,Charles A. Simonton,Frank D. Kolodgie,Renu Virmani +10 more
TL;DR: Overall, EES and R-ZES displayed similar remodeling properties with lower arterial drug levels observed in the EES group vs the R- zotarolimus-eluting stent, which may have led to more rapid endothelial maturation.
33
Pathology and Vulnerability of Atherosclerotic Plaque: Identification, Treatment Options, and Individual Patient Differences for Prevention of Stroke
TL;DR: Improvements in MRI, particularly high-resolution gadolinium-enhanced MRI, currently make this modality the most informative technology, as it allows easy identification of lesion morphometry, calcification, and hemorrhage.
33
Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model.
Michael J. Lipinski,Eduardo Acampado,Qi Cheng,Lila Adams,Sho Torii,Jiaxiang Gai,Rebecca Torguson,David Hellinga,Michael Joner,Claus Harder,Philine Zumstein,Aloke V. Finn,Frank D. Kolodgie,Renu Virmani,Ron Waksman +14 more
TL;DR: In this paper, the Magmaris resorbable magnesium scaffold (RMS) has platelet-repelling properties by comparing its acute thrombogenicity with an equivalent stainless steel stent in an arteriovenous shunt model.
33
In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings.
Nathan A. Lockwood,Robert W. Hergenrother,Laura Marie Patrick,Sean M. Stucke,Rob Steendam,Erica Pacheco,Renu Virmani,Frank D. Kolodgie,Brad Hubbard +8 more
TL;DR: In vitro and in vivo results suggest that SynBiosys urethane-linked MBCP and Eureka SOLO hydrophobic MD polymer families possess the physical and chemical properties and vascular biocompatibility necessary for further investigation for use in the next generation of drug-eluting stents.
32
Drug-eluting coronary stent very late thrombosis revisited.
Peter Lanzer,Katrin Sternberg,Klaus-Peter Schmitz,Frank D. Kolodgie,Gaku Nakazawa,Renu Virmani +5 more
TL;DR: Drug-eluting stents (DES) provide a significant additional reduction in restenosis rates and the need for coronary reinterventions and future risk avoidance strategies are briefly reviewed and commented.
32